Pyrexia and normal C-reactive protein (CRP) in patients with systemic lupus erythematosus: Always consider the possibility of infection in febrile patients with systemic lupus erythematosus regardless of CRP levels [9]

Rheumatology

Volumn 40, Issue 3, 2001, Pages 349-350

  Roy, S ^a,b   Tan, K T ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BENDROFLUMETHIAZIDE; C REACTIVE PROTEIN; CIPROFLOXACIN; COCODAMOL; FLUCLOXACILLIN; NIZATIDINE; PREDNISOLONE; STEROID;

ADULT; BACTERIAL INFECTION; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; FEMALE; FEVER; HUMAN; LETTER; PRIORITY JOURNAL; SALMONELLOSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SALMONELLA INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 0035065071     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study
2. Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus
3. Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus
4. Autoantibodies to C-reactive protein and other acute phase proteins in systemic autoimmune disease